Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Avoro Capital Advisors LLC
Form 13F · Q2 2026

Avoro Capital Advisors LLC

CIK 1633313申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$111.4亿
申報組合市值
26
持倉數量
12
Quarters on record
Top 50
持倉數量

Avoro Capital Advisors LLC——持倉

共 26 個持倉中的前 26 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1UTHR United Therapeutics Corp Del2.8M+5.6%$15.1亿13.5%
2ASND Ascendis Pharma A/S5.1M—$13.6亿12.2%
3KRYS Krystal Biotech Inc2.9M+0.0%$10.7亿9.6%
4MDGL Madrigal Pharmaceuticals Inc1.8M+0.8%$9.8亿8.8%
5ARGX Argenx Se1.0M+0.0%$9.3亿8.3%
6ARWR Arrowhead Pharmaceuticals In11.4M+6.1%$9.3亿8.3%
7KYMR Kymera Therapeutics Inc7.5M+0.0%$8.6亿7.7%
8RVMD Revolution Medicines Inc2.3M−2.0%$4.3亿3.9%
9CYTK Cytokinetics Inc5.0M+50.0%$4.3亿3.8%
10CELC Celcuity Inc3.4M+0.7%$3.6亿3.2%
11GPCR Structure Therapeutics Inc6.6M+0.0%$3.5亿3.2%
12XENE Xenon Pharmaceuticals Inc5.8M+0.0%$3.5亿3.1%
13DFTX Definium Therapeutics Inc7.2M+43.8%$3.4亿3.0%
14UNIQURE NV Uniqure Nv6.7M+12.9%$3.1亿2.8%
15VERA Vera Therapeutics Inc5.7M−2.8%$2.5亿2.2%
16TSHA Taysha Gene Therapies Inc23.9M+10.1%$1.6亿1.5%
17OCUL Ocular Therapeutix Inc12.5M+1.8%$1.2亿1.1%
18DMRA Damora Therapeutics Inc3.8M+0.0%$9840万0.9%
19COAG Hemab Therapeutics Hldgs Inc1.9M—$7071万0.6%
20GHRS Gh Research Plc1.8M+0.0%$4838万0.4%
21VRDN Viridian Therapeutics Inc2.5M+66.7%$4592万0.4%
22SEPN Septerna Inc1.3M+0.0%$4479万0.4%
23AVTX Avalo Therapeutics Inc2.3M+65.5%$4312万0.4%
24FTH Faeth Therapeutics Inc1.4M—$3610万0.3%
25WHWK Whitehawk Therapeutics Inc2.8M+0.0%$1305万0.1%
26LXEO Lexeo Therapeutics Inc1.5M−20.6%$693万0.1%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。